TDB Backs Autoscope AI Whole Slide Imaging System
Technology

TDB Backs Autoscope AI Whole Slide Imaging System

The Technology Development Board (TDB) of the Department of Science and Technology (DST) has entered into an agreement with Ayukriyam Innovations Pvt. Ltd. to develop Autoscope, a fully automated whole slide imaging and artificial intelligence (AI) driven diagnostic system. The project is intended to promote deep?tech innovation and technological self?reliance in healthcare by translating laboratory research into marketable solutions. The assistance aims to reduce import dependence for high?end imaging systems and to support Aatmanirbhar Bharat objectives.

Ayukriyam Innovations Pvt. Ltd. is a deep?tech spin?off from the Molecular Imaging and Diagnostics Lab in the Department of Biochemical Engineering and Biotechnology at the Indian Institute of Technology Delhi (IIT Delhi). The company is focused on microscopy systems integrated with AI to enable rapid and deployable diagnosis of infectious diseases, particularly in resource?constrained settings. The developers are pursuing standardised, scalable workflows suitable for wider clinical adoption.

The Autoscope platform is being developed as a whole slide imaging system combined with AI driven image analytics to offer high throughput and standardised diagnostic workflows. The system seeks to enhance diagnostic accuracy while reducing dependence on imported equipment through indigenous research and development. Field performance evaluations are planned to assess clinical utility and operational scalability across diverse healthcare settings.

The sanctioned assistance from TDB will support establishment of a dedicated manufacturing facility, production of multiple product batches, and comprehensive field evaluations to prepare the platform for commercialisation. TDB reiterated its mandate to provide financial assistance for commercialisation of indigenous technologies developed through institutional research linkages and the Government underlined continued commitment to innovation?led growth in healthcare. The Secretary of TDB indicated that indigenous development of integrated imaging and AI platforms is vital for strengthening healthcare infrastructure, and the promoters of Ayukriyam conveyed that the support would accelerate manufacturing readiness and field deployment.

The Technology Development Board (TDB) of the Department of Science and Technology (DST) has entered into an agreement with Ayukriyam Innovations Pvt. Ltd. to develop Autoscope, a fully automated whole slide imaging and artificial intelligence (AI) driven diagnostic system. The project is intended to promote deep?tech innovation and technological self?reliance in healthcare by translating laboratory research into marketable solutions. The assistance aims to reduce import dependence for high?end imaging systems and to support Aatmanirbhar Bharat objectives. Ayukriyam Innovations Pvt. Ltd. is a deep?tech spin?off from the Molecular Imaging and Diagnostics Lab in the Department of Biochemical Engineering and Biotechnology at the Indian Institute of Technology Delhi (IIT Delhi). The company is focused on microscopy systems integrated with AI to enable rapid and deployable diagnosis of infectious diseases, particularly in resource?constrained settings. The developers are pursuing standardised, scalable workflows suitable for wider clinical adoption. The Autoscope platform is being developed as a whole slide imaging system combined with AI driven image analytics to offer high throughput and standardised diagnostic workflows. The system seeks to enhance diagnostic accuracy while reducing dependence on imported equipment through indigenous research and development. Field performance evaluations are planned to assess clinical utility and operational scalability across diverse healthcare settings. The sanctioned assistance from TDB will support establishment of a dedicated manufacturing facility, production of multiple product batches, and comprehensive field evaluations to prepare the platform for commercialisation. TDB reiterated its mandate to provide financial assistance for commercialisation of indigenous technologies developed through institutional research linkages and the Government underlined continued commitment to innovation?led growth in healthcare. The Secretary of TDB indicated that indigenous development of integrated imaging and AI platforms is vital for strengthening healthcare infrastructure, and the promoters of Ayukriyam conveyed that the support would accelerate manufacturing readiness and field deployment.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code